-
A New Milestone in Brain Tumor Imaging: FDA Approves Pixclara (floretyrosine F 18)
Advancing Glioma Diagnostics The landscape of neuro-oncology has seen a significant advancement with the recent FDA approval of Pixclara (floretyrosine F 18). This new radioactive diagnostic agent is set to change how clinicians visualize and manage gliomas, which are among the most challenging brain tumors to diagnose and monitor. Understanding Pixclara Pixclara is an amino…
-
A New Milestone in Alzheimer’s Diagnostics: FDA Approves Tauvid (Tauklartify)
NASDAQ: $LNTH Understanding the Breakthrough The landscape of Alzheimer’s disease diagnosis has taken a significant step forward. The FDA has officially approved Tauklartify (florquinitau F 18), a groundbreaking diagnostic agent designed to assist healthcare professionals in evaluating patients with cognitive impairment. How It Works Tauklartify is an F 18-labeled tau positron emission tomography (PET) imaging…